Glaxo to collaborate with CureVac on mRNA Covid-19 vaccines
GlaxoSmithKline Plc agreed to work with Germany’s CureVac on as many as five novel mRNA vaccines that will target infectious diseases as Covid-19 pushes companies and governments to focus on…